Table 3 Associations of hyperuricemia and laterality of prevalent of knee synovial abnormalities on ultrasound
Synovial abnormalities | Hyperuricemia | |
|---|---|---|
No | Yes | |
Knee synovial abnormality* | Â | Â |
 No, n (%) | 1,476 (51.7) | 268 (48.6) |
 Unilateral, n (%) | 795 (27.9) | 160 (29.0) |
 Bilateral, n (%) | 583 (20.4) | 123 (22.3) |
 Crude OR (95% CI) | 1.00 (reference) | 1.13 (0.95, 1.34) |
 Adjusted OR (95% CI)†| 1.00 (reference) | 1.24 (1.03, 1.50) |
Synovial hypertrophy | Â | Â |
 No, n (%) | 2,378 (83.3) | 429 (77.9) |
 Unilateral, n (%) | 362 (12.7) | 90 (16.3) |
 Bilateral, n (%) | 114 (4.0) | 32 (5.8) |
 Crude OR (95% CI) | 1.00 (reference) | 1.42 (1.14, 1.78) |
 Adjusted OR (95% CI)†| 1.00 (reference) | 1.35 (1.05, 1.73) |
Joint effusion | Â | Â |
 No, n (%) | 1,537 (53.9) | 283 (51.4) |
 Unilateral, n (%) | 791 (27.7) | 155 (28.1) |
 Bilateral, n (%) | 526 (18.4) | 113 (20.5) |
 Crude OR (95% CI) | 1.00 (reference) | 1.12 (0.94, 1.33) |
 Adjusted OR (95% CI)†| 1.00 (reference) | 1.25 (1.03, 1.51) |
Power Doppler signal | Â | Â |
 No, n (%) | 2,728 (95.6) | 511 (92.7) |
 Unilateral, n (%) | 108 (3.8) | 34 (6.2) |
 Bilateral, n (%) | 18 (0.6) | 6 (1.1) |
 Crude OR (95% CI) | 1.00 (reference) | 1.70 (1.17, 2.45) |
 Adjusted OR (95% CI)†| 1.00 (reference) | 1.42 (0.94, 2.16) |